February 3, 2024 Comments Off on New patent expiration for MYLAN drug EVOCLIN Posted in: Uncategorized
Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…
The post New patent expiration for MYLAN drug EVOCLIN appeared first on DrugPate…
February 3, 2024 Comments Off on New patent for Ocuphire drug RYZUMVI Posted in: Patent Added Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…
